公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1997 | Immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 2 | |
2020 | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) | Chang F.-Y.; Chen H.-C.; PEI-JER CHEN ; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K. | Journal of Biomedical Science | 34 | 26 | |
2011 | Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; PEI-JER CHEN ; ZHONG-ZHE LIN ; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; CHIH-HUNG HSU ; ANN-LII CHENG | Anticancer Research | 12 | ||
2012 | Impact of hepatitis B virus infection on metabolic profiles and modifying factors | Hsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 60 | 54 | |
2007 | Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; JIA-HORNG KAO ; SUI-YUAN CHANG ; Chen M.-Y.; SZU-MIN HSIEH ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 73 | 60 | |
2000 | Impact of human genome research on medicine - The initial Taiwan experience | Tsai S.-F.; PEI-JER CHEN | Journal of the Formosan Medical Association | 1 | 1 | |
2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
1992 | Inactivation of the retinoblastoma gene in acute myelogenous leukaemia | JIH-LUH TANG ; Shiou-Hwei Yeh ; PEI-JER CHEN ; Lin M.-T.; HWEI-FANG TIEN ; YAO-CHANG CHEN | British Journal of Haematology | 38 | 34 | |
2010 | Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection | Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; TAI-CHUNG TSENG ; Chen C.-H.; Su W.-C.; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 14 | 16 | |
2002 | Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan | MING-WHEI YU ; Chang H.-C.; PEI-JER CHEN ; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. | International Journal of Epidemiology | 27 | 27 | |
2004 | Induction of humoral and cellular immune responses to hepatitis delta virus through DNA immunization in BALB/c mice. | Lee R.S.; SHIH-JER HSU ; Huang L.R.; Wu H.L.; Lin S.L.; DING-SHINN CHEN ; PEI-JER CHEN | Methods in molecular medicine | 0 | 0 | |
2004 | Infection Control and SARS Transmission among Healthcare Workers, Taiwan | YEE-CHUN CHEN ; PEI-JER CHEN ; SHAN-CHWEN CHANG ; CHUAN-LIANG KAO ; Wang S.-H; Wang L.-H; PAN-CHYR YANG ; DING-SHINN CHEN ; Lee Y.-T; Teng C.-M; HONG-NERNG HO ; MING-FU CHANG ; JIN-TOWN WANG ; Wang W.-K; Hsiao C.-H; PO-REN HSUEH | Emerging Infectious Diseases | 54 | 41 | |
2005 | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C | CHUN-JEN LIU ; YUNG-MING JENG ; PEI-JER CHEN ; Lai M.-Y; HUNG-CHIH YANG ; Huang W.-L; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 34 | 32 | |
2012 | Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors | Huang C.-H.; Yuan Q.; PEI-JER CHEN ; Zhang Y.-L.; Chen C.-R.; Zheng Q.-B.; Shiou-Hwei Yeh ; Yu H.; Xue Y.; Chen Y.-X.; Liu P.-G.; Ge S.-X.; Zhang J.; Xia N.-S. | Journal of Hepatology | 164 | 146 | |
2012 | Influences of tobacco and alcohol use on hepatocellular carcinoma survival | WEI-LIANG SHIH ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; CHUN-JEN LIU ; Lin C.-L.; MING-WHEI YU | International Journal of Cancer | 49 | 44 | |
2012 | Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells | Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN ; ANN-LII CHENG | Biochemical Pharmacology | 50 | 50 | |
1997 | Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides | Chia J.-S.; Wu H.-L.; Wang H.-W.; Chen D.-S.; PEI-JER CHEN | Journal of Biomedical Science | 43 | 38 | |
1995 | Inhibition of α-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues | Lin S.-B.; Huang S.-S.; Choo K.-B.; PEI-JER CHEN ; Au L.-C. | Journal of Biochemistry | 7 | 8 | |
2006 | Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study | CHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 41 | 35 | |
2003 | Interferon-α reduces insulin resistance and β-cell secretion in responders among patients with chronic hepatitis B and C | TONG-YUAN TAI ; JIN-YING LU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; Lee, Cha-Ze ; Lee, Hsuan-Shu ; LEE-MING CHUANG ; YUNG-MING JENG | Journal of Endocrinology | 39 | 35 |